Directorate Change

RNS Number : 8927J
Omega Diagnostics Group PLC
10 December 2018
 

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

 

Directorate Change

 

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that David Evans, Chairman of the Company, has resigned from the Board and stepped down with immediate effect.  

 

Bill Rhodes has agreed to act as interim Chairman.  Under David's leadership, the Company had already been in the process of identifying and recruiting an additional Non-Executive Director to further strengthen the Board.  During that process, David decided that after 18 years' service, the opportunity to also bring fresh perspective from the position of Chairman would enable the Board to focus on the reshaped business and new opportunities that lie ahead.

 

Colin King, Chief Executive of Omega Diagnostics, commented: "The Board would like to thank David for his invaluable contribution during his 18 years of service and wish him all the best for the future."

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

Contacts: 

 

Omega Diagnostics Group PLC                         

Tel: 01259 763 030

Bill Rhodes, Interim Non-Executive Chairman

Colin King, Chief Executive                             

www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director



Mob: 07740 084452



finnCap Ltd                                              

Tel: 020 7220 0500

Geoff Nash/James Thompson (Corporate Finance)


Camille Gochez (Corporate Broking)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAEANESNPFAF
UK 100

Latest directors dealings